Mohamed Badawi

2.7k total citations · 1 hit paper
60 papers, 1.8k citations indexed

About

Mohamed Badawi is a scholar working on Molecular Biology, Plant Science and Hematology. According to data from OpenAlex, Mohamed Badawi has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Plant Science and 13 papers in Hematology. Recurrent topics in Mohamed Badawi's work include Plant Stress Responses and Tolerance (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Plant-Microbe Interactions and Immunity (7 papers). Mohamed Badawi is often cited by papers focused on Plant Stress Responses and Tolerance (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Plant-Microbe Interactions and Immunity (7 papers). Mohamed Badawi collaborates with scholars based in United States, Canada and Egypt. Mohamed Badawi's co-authors include Fathey Sarhan, Thomas D. Schmittgen, Mitch A. Phelps, Dhruvitkumar S. Sutaria, Mario Houde, Jinmai Jiang, Jean Danyluk, Ola A. Elgamal, Xiaohua Zhu and Steven Pomeroy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Mohamed Badawi

58 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells

2017 447 citations Mohamed Badawi, Dhruvitkumar S. Sutaria et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohamed Badawi United States	21	1.1k	565	431	110	95	60	1.8k
Qing Kang United States	19	1.2k 1.1×	134 0.2×	850 2.0×	255 2.3×	103 1.1×	82	2.0k
Craig A. Hodges United States	27	1.5k 1.4×	279 0.5×	231 0.5×	74 0.7×	137 1.4×	58	3.1k
Ying Gu China	25	1.7k 1.5×	127 0.2×	203 0.5×	135 1.2×	134 1.4×	116	2.5k
Huan Wu China	28	988 0.9×	158 0.3×	245 0.6×	171 1.6×	116 1.2×	118	2.4k
Rinaldo Wellerson Pereira Brazil	23	920 0.8×	238 0.4×	273 0.6×	78 0.7×	238 2.5×	88	2.1k
Richard Shen United States	15	2.4k 2.2×	363 0.6×	442 1.0×	152 1.4×	148 1.6×	22	3.5k
Bo Zhou China	22	1.3k 1.2×	147 0.3×	364 0.8×	207 1.9×	222 2.3×	72	2.2k
Rachel Butler United Kingdom	24	1.2k 1.1×	238 0.4×	374 0.9×	585 5.3×	135 1.4×	61	2.5k
Carol Wilson United States	23	783 0.7×	642 1.1×	232 0.5×	410 3.7×	56 0.6×	99	2.4k
Jun Song China	25	1.5k 1.4×	233 0.4×	154 0.4×	219 2.0×	176 1.9×	81	2.3k

Countries citing papers authored by Mohamed Badawi

Since Specialization

Citations

This map shows the geographic impact of Mohamed Badawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Badawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Badawi more than expected).

Fields of papers citing papers by Mohamed Badawi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Badawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Badawi. The network helps show where Mohamed Badawi may publish in the future.

Co-authorship network of co-authors of Mohamed Badawi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Badawi. A scholar is included among the top collaborators of Mohamed Badawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Badawi. Mohamed Badawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schulz, J, Alix F. Leblanc, Ekram Ahmed Chowdhury, et al.. (2025). Optimization of Bottom‐Up PBPK Model Development in SIMCYP via Retrospective Analysis of Clinical Human PK Data. Clinical and Translational Science. 18(11). e70417–e70417.

Badawi, Mohamed, et al.. (2024). Exposure-response relationships of venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory t(11;14) multiple myeloma patients. Investigational New Drugs. 42(6). 635–643. 2 indexed citations

Badawi, Mohamed, Sathej Gopalakrishnan, Tammy L. Palenski, et al.. (2024). Dosing of Venetoclax in Pediatric Patients with Relapsed Acute Myeloid Leukemia: Analysis of Developmental Pharmacokinetics and Exposure-Response Relationships. Clinical Therapeutics. 46(10). 759–767.

Herling, Marco, Claire Dearden, Francesco Zaja, et al.. (2024). Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study. Blood Advances. 8(4). 842–845. 2 indexed citations

Chong, Elise A., Junichiro Yuda, Koji Izutsu, et al.. (2024). A first-in-human study of the potent and highly selective BTK degrader ABBV-101 in patients with relapsed/refractory B-cell malignancies.. Journal of Clinical Oncology. 42(16_suppl). TPS7091–TPS7091. 3 indexed citations

Badawi, Mohamed, Sathej Gopalakrishnan, Weize Huang, et al.. (2023). Venetoclax in biomarker‐selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety. Hematological Oncology. 42(1). e3222–e3222. 4 indexed citations

Badawi, Mohamed, Xin Chen, Patrick Marroum, et al.. (2022). Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet. Clinical Drug Investigation. 42(8). 657–668. 6 indexed citations

Badawi, Mohamed, Ahmed A. Suleiman, Jonathan L. Kaufman, et al.. (2022). Exposure-Response Analysis Supports a Lower Dose of Venetoclax in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Patients When Combined with Daratumumab and Dexamethasone. Blood. 140(Supplement 1). 10122–10123. 2 indexed citations

Badawi, Mohamed. (2022). Co-Composting Date Palm Tree Wastes and its Effects on Soil Fertility. Key engineering materials. 925. 73–83. 2 indexed citations

10.

Rotow, Julia, Kiyotaka Yoh, Ruth Perets, et al.. (2022). 1185TiP First-in-human phase I study of ABBV-637 as monotherapy and in combination in patients with relapsed and refractory solid tumors. Annals of Oncology. 33. S1090–S1090. 2 indexed citations

11.

Thangavadivel, Shanmugapriya, Qiuhong Zhao, Narendranath Epperla, et al.. (2020). Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia. Clinical Cancer Research. 26(23). 6187–6195. 3 indexed citations

12.

Sardesai, Sagar, Mohamed Badawi, Ewa Mrózek, et al.. (2020). A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Investigational New Drugs. 38(5). 1400–1410. 24 indexed citations

13.

Rubnitz, Jeffrey E., Thomas Alexander, Theodore W. Laetsch, et al.. (2020). Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Blood. 136(Supplement 1). 12–13. 1 indexed citations

14.

Jiang, Jinmai, Ana Clara P. Azevedo‐Pouly, Roxana S. Redis, et al.. (2016). Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 7(33). 53165–53177. 39 indexed citations

15.

Kim, Ji Hye, Mohamed Badawi, Jong Kook Park, et al.. (2016). Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. International Journal of Oncology. 49(5). 2037–2045. 24 indexed citations

16.

Agharbaoui, Zahra, Mickaël Leclercq, Mohamed Badawi, et al.. (2015). An integrative approach to identify hexaploid wheat miRNAome associated with development and tolerance to abiotic stress. BMC Genomics. 16(1). 339–339. 18 indexed citations

17.

Badawi, Mohamed, Zahra Agharbaoui, Yoko Tominaga, et al.. (2008). Structure and Functional Analysis of Wheat ICE (Inducer of CBF Expression) Genes. Plant and Cell Physiology. 49(8). 1237–1249. 127 indexed citations

18.

Badawi, Mohamed, et al.. (2007). The CBF gene family in hexaploid wheat and its relationship to the phylogenetic complexity of cereal CBFs. Molecular Genetics and Genomics. 277(5). 533–554. 137 indexed citations

19.

Badawi, Mohamed, et al.. (1999). Psychopathology and attrition in the Baltimore ECA 15-year follow-up 1981-1996. Social Psychiatry and Psychiatric Epidemiology. 34(2). 91–98. 142 indexed citations

20.

Hollander, Daniel, et al.. (1978). Preliminary characterization of a small intestinal binding component for retinol and fatty acids in the rat. Life Sciences. 23(10). 1011–1017. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact